Scientists are designing mRNA vaccines to produce virus-like nanoparticles, which should lead to a more robust immune ...

A multi-institutional team led by University of Washington scientists have engineered a new vaccine platform combining mRNA and computational protein design, producing in mice a potent immune defense ...

In today’s rapidly evolving scientific landscape, eliminating barriers to progress is more critical than ever. Precision medicine and targeted therapies hold great promise but are dependent on the ...

The same groundbreaking technology that enabled rapid COVID-19 vaccine development is now poised to revolutionize medicine in ways that seemed impossible just a few years ago. Messenger RNA vaccines ...

BERNARDSVILLE, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule mRNA drugs and their mechanisms of action by phenotypic screening with AI driven ...

BERNARDSVILLE, N.J., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leading Tech.Bio in the discovery of mRNA drugs and targets, announced its third webinar, a part of their exclusive LightON ...

With support from the National Institutes of Health, the COBRE Center for RNA Biology in Health and Disease will create a ...

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.

As the Trump administration cuts federal funding for mRNA vaccine research, two top scientific efforts in New York are poised to continue forging mRNA-related breakthroughs aimed at fighting diseases ...

Waters Corporation (NYSE: WAT) today unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering unmatched ...

Researchers at Karolinska Institutet have discovered how cells can adjust their gene activity to survive when oxygen runs low ...

The Department of Health and Human Services announced Tuesday that it’s winding down $500 million in funding for the development of mRNA vaccines, which became most widely known during the COVID-19 ...